BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.358
-0.012 (-3.22%)
At close: Jan 22, 2025, 4:00 PM
0.352
-0.006 (-1.68%)
After-hours: Jan 22, 2025, 4:24 PM EST
BioNexus Gene Lab Employees
BioNexus Gene Lab had 30 employees as of December 31, 2023. The number of employees decreased by 3 or -9.09% compared to the previous year.
Employees
30
Change (1Y)
-3
Growth (1Y)
-9.09%
Revenue / Employee
$308,662
Profits / Employee
-$31,385
Market Cap
6.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CRH plc | 78,500 |
Linde | 66,323 |
The Sherwin-Williams Company | 64,088 |
Rio Tinto Group | 53,771 |
Ecolab | 48,000 |
BHP Group | 42,319 |
Freeport-McMoRan | 27,200 |
Air Products and Chemicals | 23,000 |
BGLC News
- 4 months ago - BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - GlobeNewsWire
- 4 months ago - BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - GlobeNewsWire
- 4 months ago - BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions - GlobeNewsWire
- 4 months ago - BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - GlobeNewsWire
- 5 months ago - BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd - GlobeNewsWire
- 5 months ago - BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd - GlobeNewsWire
- 9 months ago - BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - GlobeNewsWire
- 1 year ago - BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market - GlobeNewsWire